Atea Pharmaceuticals Inc. (AVIR) Social Stream



Atea Pharmaceuticals Inc. (AVIR): $7.51

0.22 (+3.02%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add AVIR to Watchlist
Sign Up

Industry: Biotech


Ranked

of 389

in industry

Atea Pharmaceuticals Inc (AVIR) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Atea Pharmaceuticals Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-12 5 $20 $14 $16.666 $6.99 138.43%
2021-11-18 5 $16 $11 $13.666 $6.99 95.51%
2021-12-15 4 $16 $11 $13.666 $6.99 95.51%
2022-01-04 4 $14 $10 $11.666 $6.99 66.9%
2022-01-06 4 $11 $7 $9.333 $6.99 33.52%
2022-01-31 4 $11 $6 $9 $6.99 28.76%
2022-02-15 4 $10 $6 $8.666 $6.99 23.98%
2022-02-28 4 $10 $6 $8.333 $6.99 19.21%
2022-03-07 4 $9 $6 $7.666 $6.99 9.67%

The Trend in the Analyst Price Target


AVIR's average price target has moved down $41.33 over the prior 13 months.

Over the past 138 days, AVIR's average upside potential has been 37.91%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-18 5 16 11 13.666 8.62 58.54%
2021-11-18 4 16 11 13.666 8.62 58.54%
2022-01-04 4 14 10 11.666 8.62 35.34%
2022-02-28 4 10 6 8.333 6.34 31.44%
2022-03-07 4 9 6 7.666 5.89 30.15%

AVIR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.83 1 0 2 1 1 4

The Trend in the Broker Recommendations


AVIR's average broker recommendation rating improved by 0 over the prior 59 days.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • AVIR has a greater average analyst price target than 92.46% of all US stocks.
  • AVIR has a greater number of analysts covering the stock than 161.51% of stocks in the mid market cap category.
  • Atea Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is greater than 183.4% of Pharmaceutical Products stocks.
  • In the context of Pharmaceutical Products stocks, Atea Pharmaceuticals Inc's variance in analysts' estimates is lower than -212.83% of them.

In the Pharmaceutical Products industry, AUPH, ATAI, and ASND are the three stocks most similar to Atea Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here.

Is AVIR a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6435 seconds.